{"database": "lobbying", "table": "lobbying_activities", "rows": [[3195385, "943f7490-b278-4bd4-bf51-7a7f1bb03407", "Q2", "RUBICON ADVISORS, LLC", 315091, "DYNAVAX TECHNOLOGIES", 2024, "second_quarter", "PHA", "Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)", "HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS)", 75000, null, 0, 0, "2024-07-17T10:01:25-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3195385"], "units": {}, "query_ms": 0.3383199218660593, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}